BioLineRx’s BKT-140/BL-8040 Receives Orphan Drug Designation for Treatment of AML

BioLineRx's BKT-140/BL-8040 Receives Orphan Drug Designation for Treatment of AML Read More

BioLineRx Announces Issuance of United States Patent

BioLineRx Announces Issuance of United States Patent Covering Use of BKT-140/BL-8040 for Obtaining Stem Cells Read More

Go to Top